Riding the Wave of Adalimumab Biosimilars: Considerations for Pediatric Gastroenterologists

J Pediatr Gastroenterol Nutr. 2023 Jun;76(6):701-703. doi: 10.1097/MPG.0000000000003757. Epub 2023 Mar 6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adalimumab / therapeutic use
  • Biosimilar Pharmaceuticals*
  • Child
  • Colitis, Ulcerative*
  • Gastroenterologists*
  • Humans
  • Infliximab / therapeutic use

Substances

  • Adalimumab
  • Biosimilar Pharmaceuticals
  • Infliximab